Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Krystal Biotech (KRYS) Prepaid Assets (2021 - 2025)

Historic Prepaid Assets for Krystal Biotech (KRYS) over the last 5 years, with Q3 2025 value amounting to $17.2 million.

  • Krystal Biotech's Prepaid Assets rose 9208.79% to $17.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.2 million, marking a year-over-year increase of 9208.79%. This contributed to the annual value of $11.7 million for FY2024, which is 7382.94% up from last year.
  • According to the latest figures from Q3 2025, Krystal Biotech's Prepaid Assets is $17.2 million, which was up 9208.79% from $16.9 million recorded in Q2 2025.
  • Krystal Biotech's Prepaid Assets' 5-year high stood at $17.2 million during Q3 2025, with a 5-year trough of $2.2 million in Q2 2021.
  • For the 5-year period, Krystal Biotech's Prepaid Assets averaged around $7.1 million, with its median value being $5.5 million (2023).
  • Per our database at Business Quant, Krystal Biotech's Prepaid Assets surged by 1047.71% in 2022 and then soared by 15828.84% in 2025.
  • Over the past 5 years, Krystal Biotech's Prepaid Assets (Quarter) stood at $4.2 million in 2021, then increased by 10.48% to $4.6 million in 2022, then surged by 45.53% to $6.7 million in 2023, then surged by 73.83% to $11.7 million in 2024, then soared by 47.66% to $17.2 million in 2025.
  • Its Prepaid Assets stands at $17.2 million for Q3 2025, versus $16.9 million for Q2 2025 and $16.8 million for Q1 2025.